Concepts (312)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 37 | 2023 | 70 | 12.280 |
Why?
|
| Obesity, Morbid | 36 | 2023 | 104 | 10.500 |
Why?
|
| Diabetes Mellitus, Type 2 | 14 | 2022 | 191 | 5.160 |
Why?
|
| Weight Loss | 20 | 2022 | 130 | 4.310 |
Why?
|
| Bariatric Surgery | 14 | 2023 | 52 | 4.220 |
Why?
|
| Laparoscopy | 29 | 2022 | 198 | 3.730 |
Why?
|
| Postoperative Complications | 13 | 2023 | 931 | 1.960 |
Why?
|
| Insulin Resistance | 6 | 2018 | 52 | 1.930 |
Why?
|
| Obesity | 8 | 2022 | 321 | 1.860 |
Why?
|
| Gastroesophageal Reflux | 12 | 2012 | 27 | 1.600 |
Why?
|
| Middle Aged | 52 | 2022 | 9254 | 1.450 |
Why?
|
| Gastrectomy | 7 | 2023 | 31 | 1.410 |
Why?
|
| Adipose Tissue | 4 | 2018 | 78 | 1.310 |
Why?
|
| Fundoplication | 10 | 2012 | 22 | 1.270 |
Why?
|
| Female | 56 | 2022 | 15708 | 1.240 |
Why?
|
| Adult | 41 | 2022 | 8097 | 1.240 |
Why?
|
| Humans | 79 | 2023 | 28408 | 1.220 |
Why?
|
| Male | 52 | 2022 | 15273 | 1.180 |
Why?
|
| Prospective Studies | 21 | 2022 | 1805 | 1.150 |
Why?
|
| Body Mass Index | 9 | 2020 | 465 | 1.110 |
Why?
|
| Gastroplasty | 6 | 2019 | 28 | 1.100 |
Why?
|
| Insulin | 4 | 2016 | 90 | 1.080 |
Why?
|
| Esophageal Achalasia | 7 | 2015 | 18 | 1.010 |
Why?
|
| Patient Education as Topic | 3 | 2014 | 160 | 0.900 |
Why?
|
| Bibliometrics | 2 | 2021 | 31 | 0.870 |
Why?
|
| General Surgery | 2 | 2021 | 54 | 0.850 |
Why?
|
| Caloric Restriction | 2 | 2014 | 16 | 0.840 |
Why?
|
| Quality of Life | 7 | 2016 | 659 | 0.830 |
Why?
|
| Treatment Outcome | 22 | 2022 | 3615 | 0.820 |
Why?
|
| Biomarkers | 3 | 2020 | 596 | 0.790 |
Why?
|
| Digestive System Surgical Procedures | 6 | 2015 | 24 | 0.790 |
Why?
|
| Adiponectin | 2 | 2012 | 10 | 0.780 |
Why?
|
| Omentum | 2 | 2012 | 8 | 0.780 |
Why?
|
| Bone Density | 2 | 2020 | 143 | 0.770 |
Why?
|
| Follow-Up Studies | 15 | 2022 | 1858 | 0.770 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 32 | 0.730 |
Why?
|
| Esophagus | 3 | 2012 | 65 | 0.710 |
Why?
|
| Case-Control Studies | 9 | 2019 | 593 | 0.710 |
Why?
|
| Weight Gain | 2 | 2021 | 66 | 0.700 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 68 | 0.690 |
Why?
|
| Osteoclasts | 1 | 2020 | 20 | 0.680 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 43 | 0.660 |
Why?
|
| Protein Precursors | 1 | 2019 | 21 | 0.660 |
Why?
|
| Mental Disorders | 1 | 2022 | 181 | 0.650 |
Why?
|
| Fractures, Bone | 1 | 2020 | 75 | 0.640 |
Why?
|
| Neoplasms | 1 | 2022 | 239 | 0.630 |
Why?
|
| Hydroxybutyrates | 1 | 2018 | 7 | 0.600 |
Why?
|
| Retrospective Studies | 15 | 2023 | 3609 | 0.590 |
Why?
|
| Postprandial Period | 3 | 2016 | 7 | 0.580 |
Why?
|
| Aged | 22 | 2022 | 9262 | 0.530 |
Why?
|
| Vascular Diseases | 1 | 2016 | 44 | 0.510 |
Why?
|
| Glucagon-Like Peptide 1 | 3 | 2016 | 11 | 0.510 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 40 | 0.500 |
Why?
|
| Adipocytes | 2 | 2012 | 21 | 0.500 |
Why?
|
| Peptide YY | 2 | 2011 | 2 | 0.480 |
Why?
|
| Leptin | 2 | 2011 | 22 | 0.480 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 372 | 0.470 |
Why?
|
| Anastomosis, Roux-en-Y | 4 | 2007 | 7 | 0.460 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2013 | 5 | 0.450 |
Why?
|
| Metabolic Syndrome | 1 | 2014 | 62 | 0.430 |
Why?
|
| Gastric Acid | 1 | 2012 | 8 | 0.410 |
Why?
|
| Time Factors | 6 | 2016 | 1490 | 0.410 |
Why?
|
| Postoperative Period | 5 | 2020 | 331 | 0.400 |
Why?
|
| Nomograms | 1 | 2012 | 6 | 0.400 |
Why?
|
| Subcutaneous Fat | 1 | 2012 | 8 | 0.390 |
Why?
|
| E2F4 Transcription Factor | 1 | 2011 | 2 | 0.390 |
Why?
|
| Appetite | 1 | 2011 | 4 | 0.390 |
Why?
|
| Blood Glucose | 4 | 2014 | 108 | 0.380 |
Why?
|
| Cell Differentiation | 1 | 2012 | 135 | 0.380 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 41 | 0.380 |
Why?
|
| Cohort Studies | 5 | 2022 | 1926 | 0.380 |
Why?
|
| Reoperation | 5 | 2021 | 917 | 0.370 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 87 | 0.360 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 155 | 0.360 |
Why?
|
| Catheter Ablation | 4 | 2004 | 72 | 0.330 |
Why?
|
| Bone and Bones | 2 | 2019 | 118 | 0.290 |
Why?
|
| Body Composition | 2 | 2021 | 69 | 0.290 |
Why?
|
| Risk Factors | 8 | 2021 | 2408 | 0.290 |
Why?
|
| Deglutition Disorders | 2 | 2007 | 35 | 0.290 |
Why?
|
| Adolescent | 7 | 2020 | 2307 | 0.290 |
Why?
|
| United States | 6 | 2022 | 2197 | 0.280 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2007 | 3 | 0.280 |
Why?
|
| Coronary Disease | 1 | 2007 | 66 | 0.270 |
Why?
|
| Young Adult | 6 | 2020 | 2069 | 0.270 |
Why?
|
| Incidence | 2 | 2022 | 773 | 0.260 |
Why?
|
| Esophagectomy | 1 | 2006 | 24 | 0.260 |
Why?
|
| Laparotomy | 2 | 2021 | 19 | 0.250 |
Why?
|
| Esophagoscopy | 5 | 2005 | 15 | 0.250 |
Why?
|
| Cholecystitis | 3 | 2023 | 10 | 0.250 |
Why?
|
| Hypoglycemia | 2 | 2016 | 13 | 0.240 |
Why?
|
| Esophageal Neoplasms | 2 | 2005 | 54 | 0.230 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2015 | 318 | 0.230 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2012 | 11 | 0.230 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 14 | 0.230 |
Why?
|
| Prognosis | 5 | 2020 | 825 | 0.220 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 87 | 0.220 |
Why?
|
| Absorptiometry, Photon | 2 | 2014 | 81 | 0.220 |
Why?
|
| Preoperative Period | 3 | 2019 | 81 | 0.220 |
Why?
|
| Transcription Factors | 1 | 2004 | 172 | 0.210 |
Why?
|
| Apoptosis | 1 | 2004 | 205 | 0.210 |
Why?
|
| Gallstones | 1 | 2023 | 10 | 0.210 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 147 | 0.210 |
Why?
|
| Patient Readmission | 2 | 2021 | 133 | 0.210 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 274 | 0.200 |
Why?
|
| Energy Metabolism | 2 | 2021 | 55 | 0.200 |
Why?
|
| Fibronectins | 1 | 2022 | 21 | 0.200 |
Why?
|
| Remission Induction | 2 | 2016 | 90 | 0.190 |
Why?
|
| Metabolome | 1 | 2021 | 16 | 0.190 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 104 | 0.190 |
Why?
|
| Preoperative Care | 2 | 2016 | 125 | 0.190 |
Why?
|
| Comorbidity | 2 | 2021 | 500 | 0.190 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2021 | 6 | 0.180 |
Why?
|
| Cefoxitin | 1 | 2020 | 3 | 0.180 |
Why?
|
| Metronidazole | 1 | 2020 | 5 | 0.180 |
Why?
|
| Levofloxacin | 1 | 2020 | 3 | 0.180 |
Why?
|
| Cells, Cultured | 2 | 2012 | 539 | 0.180 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 239 | 0.170 |
Why?
|
| Hospital Mortality | 1 | 2021 | 147 | 0.170 |
Why?
|
| Linear Models | 2 | 2014 | 251 | 0.170 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2020 | 32 | 0.170 |
Why?
|
| Medicare | 1 | 2021 | 121 | 0.170 |
Why?
|
| Morbidity | 1 | 2020 | 58 | 0.170 |
Why?
|
| Risk Assessment | 3 | 2014 | 676 | 0.160 |
Why?
|
| Analysis of Variance | 2 | 2019 | 269 | 0.160 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 932 | 0.160 |
Why?
|
| Health Status Disparities | 1 | 2020 | 75 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 320 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 330 | 0.160 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 33 | 0.150 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 2 | 0.150 |
Why?
|
| Ideal Body Weight | 1 | 2017 | 3 | 0.140 |
Why?
|
| Length of Stay | 2 | 2017 | 328 | 0.140 |
Why?
|
| Kidney | 1 | 2018 | 175 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 192 | 0.140 |
Why?
|
| Gene Expression | 1 | 2017 | 202 | 0.130 |
Why?
|
| Patient Satisfaction | 4 | 2007 | 328 | 0.130 |
Why?
|
| Esophagogastric Junction | 3 | 2004 | 13 | 0.130 |
Why?
|
| Recurrence | 1 | 2016 | 322 | 0.120 |
Why?
|
| Gastroscopy | 2 | 2004 | 9 | 0.120 |
Why?
|
| Surveys and Questionnaires | 4 | 2007 | 1216 | 0.110 |
Why?
|
| Gastrointestinal Hormones | 1 | 2014 | 1 | 0.110 |
Why?
|
| Amino Acids | 1 | 2014 | 17 | 0.110 |
Why?
|
| Mental Health | 1 | 2016 | 122 | 0.110 |
Why?
|
| Lipids | 1 | 2014 | 52 | 0.110 |
Why?
|
| Biliopancreatic Diversion | 1 | 2013 | 1 | 0.110 |
Why?
|
| Duodenum | 1 | 2013 | 6 | 0.110 |
Why?
|
| Carbon | 1 | 2013 | 8 | 0.100 |
Why?
|
| Choline | 1 | 2013 | 5 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2014 | 207 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2013 | 31 | 0.100 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 19 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 36 | 0.100 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2011 | 1 | 0.100 |
Why?
|
| Ghrelin | 1 | 2011 | 2 | 0.100 |
Why?
|
| Neuropeptide Y | 1 | 2011 | 5 | 0.100 |
Why?
|
| Reference Values | 1 | 2012 | 194 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 97 | 0.100 |
Why?
|
| Diet, High-Fat | 1 | 2011 | 16 | 0.100 |
Why?
|
| Fasting | 1 | 2011 | 22 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 608 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 284 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2012 | 139 | 0.090 |
Why?
|
| Food | 1 | 2011 | 34 | 0.090 |
Why?
|
| Exercise | 1 | 2016 | 473 | 0.090 |
Why?
|
| Chi-Square Distribution | 3 | 2007 | 146 | 0.090 |
Why?
|
| Suture Techniques | 3 | 2007 | 157 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2012 | 308 | 0.090 |
Why?
|
| Cholecystectomy, Laparoscopic | 2 | 2015 | 36 | 0.090 |
Why?
|
| Aging | 2 | 2018 | 1549 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 281 | 0.090 |
Why?
|
| Hospitals, University | 1 | 2009 | 28 | 0.080 |
Why?
|
| Muscle, Smooth | 2 | 2006 | 12 | 0.080 |
Why?
|
| Medicaid | 1 | 2009 | 38 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 4853 | 0.080 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 19 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 128 | 0.070 |
Why?
|
| Parathyroid Hormone | 1 | 2007 | 25 | 0.070 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 36 | 0.070 |
Why?
|
| Vitamin D | 1 | 2007 | 41 | 0.070 |
Why?
|
| Surgical Instruments | 1 | 2006 | 25 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2007 | 66 | 0.070 |
Why?
|
| Tennessee | 1 | 2006 | 9 | 0.060 |
Why?
|
| Markov Chains | 1 | 2006 | 32 | 0.060 |
Why?
|
| Gastroenterostomy | 1 | 2005 | 1 | 0.060 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2006 | 22 | 0.060 |
Why?
|
| Operative Time | 2 | 2017 | 93 | 0.060 |
Why?
|
| Body Weight | 1 | 2006 | 144 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 38 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 196 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2006 | 52 | 0.060 |
Why?
|
| Monitoring, Intraoperative | 1 | 2005 | 37 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2006 | 92 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2006 | 134 | 0.060 |
Why?
|
| Endoscopy | 1 | 2007 | 182 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2006 | 80 | 0.060 |
Why?
|
| Equipment Design | 4 | 2006 | 152 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2006 | 309 | 0.060 |
Why?
|
| Choledocholithiasis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Cholecystolithiasis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2004 | 3 | 0.060 |
Why?
|
| Diet | 1 | 2006 | 220 | 0.060 |
Why?
|
| COS Cells | 1 | 2004 | 43 | 0.060 |
Why?
|
| Logistic Models | 1 | 2005 | 395 | 0.060 |
Why?
|
| Cell Division | 1 | 2004 | 83 | 0.060 |
Why?
|
| Laryngitis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Hyperthermia, Induced | 1 | 2004 | 6 | 0.060 |
Why?
|
| Laryngostenosis | 1 | 2004 | 5 | 0.060 |
Why?
|
| Calcium | 1 | 2007 | 381 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 249 | 0.050 |
Why?
|
| Animals | 2 | 2018 | 3780 | 0.050 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2023 | 5 | 0.050 |
Why?
|
| Motor Activity | 1 | 2006 | 329 | 0.050 |
Why?
|
| Bile | 2 | 1993 | 5 | 0.050 |
Why?
|
| Abdomen | 1 | 2022 | 8 | 0.050 |
Why?
|
| Pancreas | 1 | 2022 | 33 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2022 | 34 | 0.050 |
Why?
|
| Standard of Care | 1 | 2021 | 13 | 0.050 |
Why?
|
| Peritoneum | 1 | 2021 | 16 | 0.050 |
Why?
|
| Hydrocephalus | 1 | 2021 | 19 | 0.050 |
Why?
|
| Postmenopause | 1 | 2019 | 52 | 0.040 |
Why?
|
| Surgical Wound Infection | 2 | 2006 | 88 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 358 | 0.040 |
Why?
|
| Bone Development | 1 | 2018 | 32 | 0.040 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 14 | 0.040 |
Why?
|
| Colonic Pseudo-Obstruction | 1 | 1997 | 1 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2017 | 148 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 378 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2006 | 331 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 53 | 0.030 |
Why?
|
| Sigmoid Diseases | 1 | 1996 | 1 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 1996 | 2 | 0.030 |
Why?
|
| Anemia | 1 | 2017 | 94 | 0.030 |
Why?
|
| Abdominal Abscess | 1 | 1996 | 3 | 0.030 |
Why?
|
| Diverticulitis, Colonic | 1 | 1996 | 3 | 0.030 |
Why?
|
| Jejunum | 2 | 2006 | 12 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2017 | 163 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 475 | 0.030 |
Why?
|
| Diet Therapy | 1 | 2016 | 11 | 0.030 |
Why?
|
| Hypertension | 1 | 2017 | 244 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2006 | 149 | 0.030 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2015 | 2 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 781 | 0.030 |
Why?
|
| Appendectomy | 1 | 2015 | 16 | 0.030 |
Why?
|
| Manometry | 2 | 2005 | 17 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2015 | 31 | 0.030 |
Why?
|
| Conversion to Open Surgery | 1 | 2013 | 4 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 1993 | 52 | 0.030 |
Why?
|
| Biopsy | 1 | 2013 | 220 | 0.020 |
Why?
|
| Esthetics | 1 | 2012 | 12 | 0.020 |
Why?
|
| Learning Curve | 1 | 2012 | 17 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 1992 | 19 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 359 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 160 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 1990 | 27 | 0.020 |
Why?
|
| Computers | 1 | 1990 | 20 | 0.020 |
Why?
|
| Patient Selection | 1 | 2012 | 206 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2005 | 517 | 0.020 |
Why?
|
| Probability | 1 | 2007 | 90 | 0.020 |
Why?
|
| Gastric Acidity Determination | 1 | 2006 | 2 | 0.020 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2006 | 3 | 0.020 |
Why?
|
| Mesocolon | 1 | 2006 | 1 | 0.020 |
Why?
|
| Peritoneal Diseases | 1 | 2006 | 4 | 0.020 |
Why?
|
| Jejunal Diseases | 1 | 2006 | 3 | 0.020 |
Why?
|
| Mesentery | 1 | 2006 | 6 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2006 | 8 | 0.020 |
Why?
|
| Data Collection | 1 | 2007 | 98 | 0.020 |
Why?
|
| Pneumonia, Aspiration | 1 | 2006 | 7 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2006 | 12 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2006 | 110 | 0.020 |
Why?
|
| Hernia | 1 | 2006 | 9 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 2006 | 12 | 0.020 |
Why?
|
| Marital Status | 1 | 2006 | 11 | 0.020 |
Why?
|
| Needles | 1 | 2006 | 21 | 0.020 |
Why?
|
| Peptide Hormones | 1 | 2006 | 3 | 0.020 |
Why?
|
| Energy Intake | 1 | 2006 | 82 | 0.020 |
Why?
|
| Thoracoscopy | 1 | 2005 | 23 | 0.020 |
Why?
|
| Survival Rate | 1 | 2007 | 356 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2006 | 37 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2005 | 67 | 0.020 |
Why?
|
| Neuromuscular Agents | 1 | 2005 | 4 | 0.020 |
Why?
|
| Esophageal Stenosis | 1 | 2005 | 3 | 0.020 |
Why?
|
| Botulinum Toxins | 1 | 2005 | 8 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2004 | 14 | 0.010 |
Why?
|
| Choledochostomy | 1 | 2004 | 1 | 0.010 |
Why?
|
| Common Bile Duct | 1 | 2004 | 2 | 0.010 |
Why?
|
| Cholangiography | 1 | 2004 | 12 | 0.010 |
Why?
|
| Gastroscopes | 1 | 2004 | 1 | 0.010 |
Why?
|
| Esophagoscopes | 1 | 2004 | 1 | 0.010 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2004 | 2 | 0.010 |
Why?
|
| Polyvinyls | 1 | 2004 | 3 | 0.010 |
Why?
|
| Polymethyl Methacrylate | 1 | 2004 | 12 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2004 | 75 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2004 | 129 | 0.010 |
Why?
|
| Endoscopy, Digestive System | 1 | 2003 | 8 | 0.010 |
Why?
|
| Gastrointestinal Transit | 1 | 2003 | 11 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 432 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 735 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 492 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 986 | 0.010 |
Why?
|
| Acute Disease | 2 | 1993 | 208 | 0.010 |
Why?
|
| Colostomy | 1 | 1996 | 2 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 1996 | 30 | 0.010 |
Why?
|
| Drainage | 1 | 1996 | 49 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 1997 | 129 | 0.010 |
Why?
|
| Radiography | 1 | 1997 | 639 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1993 | 9 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1992 | 6 | 0.010 |
Why?
|
| Cholelithiasis | 1 | 1992 | 9 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 1990 | 9 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1990 | 17 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1992 | 441 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1990 | 372 | 0.010 |
Why?
|